Region: Philadelphia
Industry: Pharmaceutical,Life Sciences,High Tech
Service Line(s): Accounting Services
Supported an IPO that raised over $60 million, including developing accounting policies, meeting disclosure requirements, and compiling S-1 filings.
“As a small, but publicly traded company, we have numerous deadlines that need to be met. Complying with Sarbanes-Oxley, while still meeting all of our other operational needs, was daunting. The professionals that we have worked with through AC Lordi have done a terrific job of helping us stay on track and have brought considerable value-added expertise to Neose.”
Monica Klos, Controller
Company Background:
Neose is a biopharmaceutical company focused on improving protein therapeutics using its proprietary technologies.
Business Challenge:
Neose’s Accounting Department underwent changes in several key positions requiring a restructuring of the accounting/finance department. The company needed a expert professionals that could step in and take control of the day-to-day close responsibilities until the restructuring of the Accounting Department was complete.
AC Lordi Consulting Solution:
To successfully meet its interim needs, we provided Neose Technologies with seasoned accounting professionals to complete the daily close process. In addition, we helped them with other projects such as the switch to a bar coded inventory system. A partner and director at AC Lordi also review the 10-K and 10-Qs offering valuable accounting expertise where necessary.
Value Delivered:
By providing Neose with a professional who could independently complete the close and other accounting projects, the current staff was able to focus more closely on other operational issues. In addition, AC Lordi’s temporary assistance allowed Neose to take the time necessary to properly evaluate the restructuring of their Accounting Department without making imprudent decisions.